OrthoSpineNews

Menu

Relatively High EPS Growth Detected in Shares of RTI Biologics in the Health Care Supplies Industry

Dec 27, 2010 (SmarTrend(R) News Watch via COMTEX) — Below are the top 5 companies in the Health Care Supplies industry ranked by the year-over-year expected EPS growth rate. The long-term growth rate is the expected annual increase in operating EPS over the next three to five years.

RTI Biologics (RTIX) EPS is expected to grow 66.7% year-over-year, better than the company’s long-term growth rate of 16%. Based on the forward P/E of 25.9x its PEG ratio is 1.62, which signifies a premium valuation given for growth.

Synergetics USA (SURG) EPS is expected to grow 50% year-over-year, better than the company’s long-term growth rate of 20%. Based on the forward P/E of 13.1x its PEG ratio is 0.66, which signifies a discount in value relative to growth.

Cooper Cos (COO) EPS is expected to grow 37.7% year-over-year, better than the company’s long-term growth rate of 14%. Based on the forward P/E of 16.4x its PEG ratio is 1.17, which signifies a premium valuation given for growth.

Neogen (NEOG) EPS is expected to grow 29% year-over-year, better than the company’s long-term growth rate of 22.5%. Based on the forward P/E of 43.3x its PEG ratio is 1.92, which signifies a premium valuation given for growth.

Vascular Solutions (VASC) EPS is expected to grow 23% year-over-year, better than the company’s long-term growth rate of 17.5%. Based on the forward P/E of 31.7x its PEG ratio is 1.81, which signifies a premium valuation given for growth.

SmarTrend currently has shares of Synergetics USA in an Uptrend and issued the Uptrend alert on August 17, 2009 at $1.49. The stock has risen 177.2% since the Uptrend alert was issued.

Write to Chip Brian at cbrian@tradethetrend.com

Categories:   Financial

Tags:  , ,

Comments